Работы, цитирующие эту работу

Работ: 3

Работа: Efficacy and safety of favipiravir, an oral RNA-dependent RNA polymerase inhibitor, in mild-to-moderate COVID-19: A randomized, comparative, open-label, multicenter, phase 3 clinical trial

1. Repurposing of Rutan showed effective treatment for COVID-19 disease

   Shavkat Salikhov, Ibrokhim Y. Abdurakhmonov, Yuliya I. Oshchepkova +15

   СтатьяDiverse Scientific Research StudiesFrontiers in Medicine2023Цитирований: 6

   ABIABI:AkademIndex/openalex/2023.article.000825

2. Repurposing of Rutan showed effective treatment for COVID-19 disease

   Shavkat Salikhov, Ibrokhim Y. Abdurakhmonov, Jamolitdin F. Ziyavitdinov +15

   ПрепринтMedicinal Plant ResearchResearch Square2023Цитирований: 0

   ABIABI:AkademIndex/openalex/2023.preprint.000050

3. Repurposing of Rutan showed effective treatment for COVID-19 disease

   Shavkat Salikhov, Ibrokhim Y. Abdurakhmonov, Jamolitdin F. Ziyavitdinov +15

   ПрепринтMedicinal Plant ResearchResearch Square2023Цитирований: 0

   ABIABI:AkademIndex/openalex/2023.preprint.000109